1-2 of 2
Charles Phelps, MSc
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

11q Deletion (del11q) Is Not a Prognostic Factor for Adverse Outcomes for Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Treated with Ibrutinib: Pooled Data from 3 Randomized Phase 3 Studies

Thomas J. Kipps, MD, PhD, Peter Hillmen, Fatih Demirkan, MD, Sebastian Grosicki, MD PhD, Steven E. Coutre, MD, Jacqueline C. Barrientos, MD, Paul M. Barr, Ann Janssens, MD, John C. Byrd, MD, Susan M. O'Brien, MD, Graeme Fraser, MD, Ulrich Jaeger, MD, Paula Cramer, MD, Stephan Stilgenbauer, MD, Asher A. Chanan-Khan, MD, Mariya Salman, PhD, Isabelle Solman, MS, Mei Cheng, PhD, Charles Phelps, MSc, Joi Ninomoto, PharmD, Angela Howes, Danelle F. James, MD MAS, Michael Hallek
Journal: Blood
Blood (2016) 128 (22): 2042.
https://doi.org/10.1182/blood.V128.22.2042.2042
Published: 2016
Journal Articles

Early Changes in Circulating T-Cell Immune Profiles in Patients with Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Data from the Phase 3, Double-Blind HELIOS Trial

Rajendra Damle, PhD, Michael Schaffer, PhD, Shalini Chaturvedi, PhD, Charles Phelps, MSc, Regina Aquino, MSc, Michelle Mahler, MD, Mariya Salman, PhD, Angela Howes, PhD, Javier Loscertales, MD PhD, Marek Trneny, MD, Dina Ben Yehuda, MD, Alexander Pristupa, MD, Asher A. Chanan-Khan, MD, Sriram Balasubramanian, PhD
Journal: Blood
Blood (2016) 128 (22): 4397.
https://doi.org/10.1182/blood.V128.22.4397.4397
Published: 2016